Edward G. Carr
Net Worth
Last updated:
What is Edward G. Carr net worth?
The estimated net worth of Mr. Edward G. Carr is at least $5,061,303 as of 8 Oct 2021. He owns shares worth $2,769,169 as insider, has earned $105,134 from insider trading and has received compensation worth at least $2,187,000 in Abeona Therapeutics Inc..
What is the salary of Edward G. Carr?
Mr. Edward G. Carr salary is $437,400 per year as Senior Vice President, Chief Financial Officer & Chief Accounting Officer in Abeona Therapeutics Inc..
How old is Edward G. Carr?
Mr. Edward G. Carr is 56 years old, born in 1969.
What stocks does Edward G. Carr currently own?
As insider, Mr. Edward G. Carr owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | Senior Vice President, Chief Financial Officer & Chief Accounting Officer | 400,169 | $6.92 | $2,769,169 |
What does Abeona Therapeutics Inc. do?
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
Edward G. Carr insider trading
Abeona Therapeutics Inc.
Mr. Edward G. Carr has made 4 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 29,122 units of ABEO stock worth $30,607 on 8 Oct 2021.
The largest trade he's ever made was exercising 35,000 units of ABEO stock on 5 Apr 2021. As of 8 Oct 2021 he still owns at least 400,169 units of ABEO stock.
Abeona Therapeutics key executives
Abeona Therapeutics Inc. executives and other stock owners filed with the SEC:
- Mr. Edward G. Carr (56) Senior Vice President, Chief Financial Officer & Chief Accounting Officer